SYNTHESIS OF 1-[ω-(BROMOPHENOXY)ALKYL]-3-NAPHTHALENYLMETHYL DERIVATIVES OF URACIL AND THEIR ANALOGUES AS PROBABLE INHIBITORS OF HUMAN CYTOMEGALOVIRUS REPLICATION

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

A synthesis of a new series of 1-[ω-(bromophenoxy)alkyl]-uracil derivatives containing in position 3 naphthalen-1-yl-, naphthalen-2-yl-, 1-bromonaphthalen-2-ylmethyl, benzyl, and anthracene 9-methyl fragment was carried out. The antiviral properties of the synthesized compounds were studied against human cytomegalovirus. It was found that the compound, which has in its composition a bridge consisting of five methylene groups, has a high anti-cytomegalovirus activity in vitro.

About the authors

M. P. Paramonova

Volgograd State Medical University

Email: snk1952@gmail.com
Russian, Volgograd

E. S. Gureeva

Volgograd State Medical University

Email: snk1952@gmail.com
Russian, Volgograd

A. A. Ozerov

Volgograd State Medical University

Email: snk1952@gmail.com
Russian, Volgograd

R. Snoeck

Rega Institute for Medical Research, KU Leuven

Email: snk1952@gmail.com
Belgium, B-3000, Leuven, Herestraat 49 bus 1043

G. Andrei

Rega Institute for Medical Research, KU Leuven

Email: snk1952@gmail.com
Belgium, B-3000, Leuven, Herestraat 49 bus 1043

D. A. Aleksandrov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: snk1952@gmail.com
Russian, Moscow

A. L. Khandazhinskaya

Institute of Molecular Biology, Russian Academy of Sciences, V.A. Engelhardt RAS

Author for correspondence.
Email: khandazhinskaya@bk.ru
Russian, Moscow

M. S. Novikov

Volgograd State Medical University

Email: snk1952@gmail.com
Russian, Volgograd

S. N. Kochetkov

Institute of Molecular Biology, Russian Academy of Sciences, V.A. Engelhardt RAS

Author for correspondence.
Email: snk1952@gmail.com
Russian, Moscow

References

  1. Rodríguez-Goncer I., Fernández-Ruiz M., Aguado J.M. // Expert Rev. Anti. Infect. Ther. 2020. V. 18. P. 113–125.
  2. Karrer U., Mekker A., Wanke K., Tchang V., Haeberli L. // Exp. Gerontol. 2009. V. 44. P. 689–694.
  3. Jentzer A., Veyrard P., Roblin X., Saint-Sardos P., Rochereau N., Paul S., Bourlet T., Pozzetto B., Pillet S. // Microorganisms. 2020. V. 8. P. 1078.
  4. Richardson A.K., Walker L.C., Cox B., Rollag H., Robin-son B.A., Morrin H., Pearson J.F., Potter J.D., Paterson M., Surcel H.M., Pukkala E., Currie M.J. // Clin. Transl. Oncol. 2020. V. 22. P. 585–602.
  5. Lv Y.L., Han F.F., An Z.L., Jia Y., Xuan L.L., Gong L.L., Zhang W., Ren L.L., Yang S., Liu H., Liu L.H. // Intervirology. 2020. V. 63. P. 10–16.
  6. Plotkin S.A., Boppana S.B. // Vaccine. 2019. V. 37. P. 7437–7442.
  7. Permar S.R., Schleiss M.R., Plotkin S.A. // J. Virol. 2018. V. 92. P. e00030-18.
  8. Kotton C.N. // Curr Opin Organ Transplant. 2019. V. 24. P. 469–475.
  9. Sellar R.S., Peggs K.S. // Expert Opin. Biol. Ther. 2012. V. 12. P. 1161–1172.
  10. Faure E., Galperine T., Cannesson O., Alain S., Gnemmi V., Goeminne C., Dewilde A., Béné J., Lasri M., Lessore de Sainte Foy C., Lionet A. // Medicine. 2016. V. 95. P. e5226.
  11. Tan B.H. // Options Infect. Dis. 2014. V. 6. P. 256–270.
  12. El Helou G., Razonable R.R. // Infect. Drug Resist. 2019. V. 12. P. 1481–1491.
  13. Papanicolaou G.A., Silveira F.P., Langston A.A., Pereira M.R., Avery R.K., Uknis M., Wijatyk A., Wu J., Boeckh M., Marty F.M., Villano S. // Clin. Infect. Dis. 2019. V. 68. P. 1255–1264.
  14. Piret J., Boivin G. // Antiviral Res. 2019. V. 163. P. 91–105.
  15. Novikov M.S., Babkov D.A., Paramonova M.P., Khandazhinskaya A.L., Ozerov A.A., Chizhov A.O., Andrei G., Snoeck R., Balzarini J., Seley-Radtke K.L. // Bioorg. Med. Chem. 2013. V. 21. P. 4151–4157.
  16. Babkov D.A., Khandazhinskaya A.L., Chizhov A.O., Andrei G., Snoeck R., Seley-Radtke K.L., Novikov M.S. // Bioorg. Med. Chem. 2015. V. 23. P. 7035–7044.
  17. Maruyama T., Kozai S., Yamasaki T., Witvrouw M., Pannecouque C., Balzarini J., Snoeck R., Andrei G., De Clercq E. // Antivir. Chem. Chemother. 2003. V. 14. P. 271–279.
  18. Maruyama T., Demizu Y., Kozai S., Witvrouw M., Pannecouque C., Balzarini J., Snoecks R., Andrei G., De Clercq E. // Nucleosides Nucleotides Nucleic Acids. 2007. V. 26. P. 1553–1558.
  19. Novikov M.S., Valuev-Elliston V.T., Babkov D.A., Paramonova M.P., Ivanov A.V., Gavryushov S.A., Khandazhinskaya A.L., Kochetkov S.N., Pannecouque C., Andrei G., Snoeck R., Balzarini J., Seley-Radtke K.L. // Bioorg. Med. Chem. 2013. V. 21. P. 1150–1158.
  20. Paramonova M.P., Khandazhinskaya A.L., Ozerov A.A., Kochetkov S.N., Snoeck R., Andrei G., Novikov M.S. // Acta Naturae. 2020. V. 12. P. 134–139.
  21. Paramonova M.P., Snoeck R., Andrei G., Khandazhinskaya A.L., Novikov M.S. // Mendeleev Commun. 2020. V. 30. P. 602–603.
  22. Snoeck R., Sakuma T., De Clercq E., Rosenberg I., Holy A. // Antimicrob. Agents Chemother. 1988. V. 32. P. 1839–1844.
  23. Baker B.R., Kelley J.L. // J. Med. Chem. 1970. V. 13. P. 458–461.

Supplementary files

Supplementary Files
Action
1. JATS XML
2.

Download (100KB)
3.

Download (45KB)
4.

Download (55KB)
5.

Download (46KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies